Abstract
Skin cancer is one of the most prevalent forms of cancer, comprising two major types: non-melanoma and melanoma. The major cause behind development of skin cancer is the continuous and prolonged exposure to ultraviolet radiations. Screening and early detection of skin cancer is very crucial for the treatment of this disorder. Treatments involve the usage of topical drugs, photodynamic therapy, radiotherapy, other than surgery. The most significant preventive measure to avoid skin cancer is minimal exposure to ultraviolet radiations. Through the course of this chapter, we will discuss about the types, classifications, epidemiology, mechanisms of skin cancer development, screening, diagnosis, treatments, and preventive measures for skin cancer.
Abbreviations
- AK:
-
Actinic keratosis
- ASIP:
-
Agouti signaling protein
- BCC:
-
Basal cell carcinoma
- CDK4:
-
Cyclin-dependent kinase 4
- CDKN2A:
-
Cyclin-dependent kinase inhibitor 2A
- CMM:
-
Cutaneous malignant melanoma
- GPX:
-
Glutathione peroxidase
- HT:
-
Helical tomotherapy
- MC1R:
-
Melanocortin 1 receptor
- MCC:
-
Merkel cell carcinoma
- NMSC:
-
Non-melanoma skin cancer
- ROS:
-
Reactive oxygen species
- SCC:
-
Squamous cell carcinoma
- SHH:
-
Sonic hedgehog
- TGF-β:
-
Transforming growth factor-β
- TLR:
-
Toll-like receptor
- TYR:
-
tyrosinase
- TYRP1:
-
Tyrosinase-related protein 1
- UV:
-
Ultraviolet
References
Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D (2017) Epidemiological trends in skin cancer. Dermatol Pract Concept 7(2):1–6
Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, Binder M, Cerroni L, De Rosa G, Ferrara G, Hofmann-Wellenhof R, Landthaler M, Menzies SW, Pehamberger H, Piccolo D, Rabinovitz HS, Schiffner R, Staibano S, Stolz W, Bartenjev I, Kopf AW (2003) Dermoscopy of pigmented skin lesions: results of a consensus meeting via the internet. J Am Acad Dermatol 48(5):679–693
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL (2006) Hedgehog signalling in skin development and cancer. Exp Dermatol 15(9):667–677
Barnhill RL, Mihm MC Jr (1993) The histopathology of cutaneous malignant melanoma. Semin Diagn Pathol 10(1):47–75
Becker JC, Zur Hausen A (2014) Cells of origin in skin cancer. J Investig Dermatol 134(10):2491–2493
Berhane T, Halliday GM, Cooke B, Barnetson RSC (2002) Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol 146(5):810–815
Bishop BN, Lynch DT (2021) Kaposi Sarcoma. In: StatPearls [Internet]. StatPearls Publishing
Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN (2003) p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res 9(1):228–234
Brady M, Spiker AM (2018) Merkel cell carcinoma of the skin
Bronner MP, Culin C, Reed JC, Furth EE (1995) The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146(1):20
Callen JP, Bickers DR, Moy RL (1997) Actinic keratoses. J Am Acad Dermatol 36(4):650–653
Chen AC, Halliday GM, Damian DL (2013) Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology 45(3):331–341
Cohen DK, Lee PK (2016) Photodynamic therapy for non-melanoma skin cancers. Cancers 8(10):90
Cowen EW, Nguyen JC, Miller DD, McShane D, Arron ST, Prose NS et al (2010) Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol 62(1):31–37
Crowson AN (2006) Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 19(2):S127–S147
de Vries E, Trakatelli M, Kalabalikis D, Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D et al (2012) Known and potential new risk factors for skin cancer in European populations: a multicentre case–control study. Br J Dermatol 167:1–13
Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146:1–6
Duarte AF, Sousa-Pinto B, Azevedo LF, Barros AM, Puig S, Malvehy J, Haneke E, Correia O (2021) Clinical ABCDE rule for early melanoma detection. Eur J Dermatol 31(6):771–778
Dubas LE, Ingraffea A (2013) Nonmelanoma skin cancer. Facial Plast Surg Clin 21(1):43–53
Duffy DL, Zhao ZZ, Sturm RA, Hayward NK, Martin NG, Montgomery GW (2010) Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J Investig Dermatol 130(2):520–528
Friedman RJ, Rigel DS, Kopf AW (1985) Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 35(3):130–151
Godic A, Poljšak B, Adamic M, Dahmane R (2014) The role of antioxidants in skin cancer prevention and treatment. Oxidative Med Cell Longev 2014:860479
Gong HZ, Zheng HY, Li J (2019) Amelanotic melanoma. Melanoma Res 29(3):221–230
Gross K, Kircik L, Kricorian G (2007) 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 33(4):433–440
Gudbjartsson DF, Sulem P, Stacey SN, Goldstein AM, Rafnar T, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Sveinsdottir SG, Magnusson V, Lindblom A, Kostulas K, Botella-Estrada R, Soriano V, JuberÃas P, Grasa M, Saez B, Andres R, Scherer D et al (2008) ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40(7):886–891
Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55(1):145–157
Hodges A, Smoller BR (2002) Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol 15(11):1121–1125
Holterhues C, Vries E, Louwman MW et al (2010) Incidence and trends of cutaneous malignancies in The Netherlands, 1989–2005. J Invest Dermatol 130:1807–1812
Kalderon D (2005) The mechanism of hedgehog signal transduction. Biochem Soc Trans 33(6):1509–1512
Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA (2002) Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 94(3):224–226
Kramkimel N, Dendale R, Bolle S, Zefkili S, Fourquet A, Kirova YM (2014) Management of advanced non-melanoma skin cancers using helical tomotherapy. J Eur Acad Dermatol Venereol 28(5):641–650
Liboutet M, Portela M, Delestaing G, Vilmer C, Dupin N, Gorin I, Saiag P, Lebbé C, Kerob D, Dubertret L, Grandchamp B, Basset-Seguin N, Soufir N (2006) MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J Invest Dermatol 126(7):1510–1517
Marks R (1996) Squamous cell carcinoma. Lancet 347(9003):735–738
Martinez JC, Otley CC (2001) The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc 76(12):1253–1265. Elsevier
McDaniel B, Badri T, Steele RB (2018) Basal cell carcinoma
Meeran SM, Punathil T, Katiyar SK (2008) IL-12 deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors. J Invest Dermatol 128(11):2716–2727
Narayanan DL, Saladi RN, Fox JL (2010) Ultraviolet radiation and skin cancer. Int J Dermatol 49(9):978–986
Nikolaou V, Stratigos AJ (2014) Emerging trends in the epidemiology of melanoma. Br J Dermatol 170(1):11–19
Nori S, Rius-DÃaz F, Cuevas J, Goldgeier M, Jaen P, Torres A, González S (2004) Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study. J Am Acad Dermatol 51(6):923–930
Nys K, Agostinis P (2012) Bcl-2 family members: essential players in skin cancer. Cancer Lett 320(1):1–13
Olbryt M (2013) Role of tumor microenvironment in the formation and progression of skin melanoma. Postepy Hig Med Dosw 67:413–432
Olsen CM, Carroll HJ, Whiteman DC (2010) Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling. Int J Cancer 127(10):2430–2445
Ott PA (2019) Intralesional cancer immunotherapies. Hematol Oncol Clin North Am 33(2):249–260. https://doi.org/10.1016/j.hoc.2018.12.009. Epub 2019 Jan 28
Panda S (2010) Nonmelanoma skin cancer in India: current scenario. Indian J Dermatol 55(4):373–378
Pierce MC, Strasswimmer J, Park BH, Cense B, De Boer JF (2004) Advances in optical coherence tomography imaging for dermatology. J Investig Dermatol 123(3):458–463
Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 122(2):464–472
Rippey JJ (1998) Why classify basal cell carcinomas? Histopathology 32(5):393–398
Ruocco E, Argenziano G, Pellacani G, Seidenari S (2004) Noninvasive imaging of skin tumors. Dermatol Surg 30:301–310
Scherer D, Nagore E, Bermejo JL, Figl A, Botella-Estrada R, Thirumaran RK, Angelini S, Hemminki K, Schadendorf D, Kumar R (2009) Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int J Cancer 125(8):1868–1875
Shishak S, Mittal A, Aswar H, Pandey R, Kalra K, Gupta A, Barwad A, Dhamija E, Shamim SA, Aggarwal A, Kaliyath SB (2021) Clinical profile and outcomes of malignant melanoma in patients from an Indian institute: A retrospective analysis. Cancer Res Stat Treat 4(4):621–627
Sokołowska-Wojdyło M, Olek-Hrab K, Ruckemann-Dziurdzińska K (2015) Primary cutaneous lymphomas: diagnosis and treatment. Postepy Dermatol Alergol 32(5):368–383
Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB (1995) Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 131(7):796–800
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Telfer NR, Colver GB, Morton CA (2008) Guidelines for the management of basal cell carcinoma. Br J Dermatol 159(1):35–48
Thomas DM, Zalcberg JR (1998) 5-fluorouracil: a pharmacological paradigm in the use of cytotoxics. Clin Exp Pharmacol Physiol 25(11):887–895
Ting W, Schultz K, Cac NN, Peterson M, Walling HW (2007) Tanning bed exposure increases the risk of malignant melanoma. Int J Dermatol 46(12):1253–1257
Trakatelli M, Ulrich C, Del Marmol V, Euvrard S, Stockfleth E, Abeni D (2007) Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 156:1–7
Tyring SK, Rosen T (2009) Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol 8(5):467–474
Veierød MB, Adami HO, Lund E, Armstrong BK, Weiderpass E (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomark Prev 19(1):111–120
Wali UK, Al-Mujaini A (2010) Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol 3(3):117–121
Walshe J, Serewko-Auret MM, Teakle N, Cameron S, Minto K, Smith L, Burcham PC, Russell T, Strutton G, Griffin A, Chu FF, Esworthy S, Reeve V, Saunders NA (2007) Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res 67(10):4751–4758
Wäster P, Rosdahl I, Gilmore BF, Seifert O (2011) Ultraviolet exposure of melanoma cells induces fibroblast activation protein-α in fibroblasts: implications for melanoma invasion. Int J Oncol 39(1):193–202
Wehner MR, Chren MM, Nameth D, Choudhry A, Gaskins M, Nead KT et al (2014) International prevalence of indoor tanning: a systematic review and meta-analysis. JAMA Dermatol 150(4):390–400
Whiteman DC, Green AC, Olsen CM (2016) The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Investig Dermatol 136(6):1161–1171
Zebracka A, Matysiak M, Dudra-Jastrzebska M, Kapka-Skrzypczak L (2015) Molecular and environmental aspects of skin cancers. J Pre-Clin Clin Res 9(2):158–162
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2024 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Kaur, H., Bhardwaj, A., Sehgal, A., Mohi, G.K., Kumar, R. (2024). Skin Cancer: An Overview. In: Sobti, R.C., Ganguly, N.K., Kumar, R. (eds) Handbook of Oncobiology: From Basic to Clinical Sciences. Springer, Singapore. https://doi.org/10.1007/978-981-99-6263-1_14
Download citation
DOI: https://doi.org/10.1007/978-981-99-6263-1_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-6262-4
Online ISBN: 978-981-99-6263-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences